跳至主要内容
临床试验/NCT04641650
NCT04641650已完成不适用

FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System in Subjects With Diabetes on HemoDIALsis (FSL-DIAL Pilot Study)

Centre Hospitalier Saint Joseph Saint Luc de Lyon1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2021年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
29
试验地点
1
主要终点
Difference between estimated Hba1c (or Glucose Management Index (GMI)) with FreeStyle Libre Pro sensor and laboratory Hba1c

研究概览

简要总结

Continuous monitoring of glucose with a FreeStyle Libre pro sensor in diabetic and dialysis patients

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes without any change in treatment in the last 3 months
  • Hemodialysis for > 3 months
  • Recent laboratory HbA1c (< 15 days)

排除标准

  • Patient does not show non-opposition
  • Skin allergy to the sensor
  • Sepsis / Acute anaemia

结局指标

主要结局

Difference between estimated Hba1c (or Glucose Management Index (GMI)) with FreeStyle Libre Pro sensor and laboratory Hba1c

时间窗: At sensor removal (day 14)

Comparison between estimated HbA1c with 14 days of CGM data and laboratory HbA1c (routine blood test in hemodialysis) in each subject

次要结局

  • Time in glucose range(At sensor removal (day 14))
  • Time with Glucose > 180 mg/dL(At sensor removal (day 14))
  • Glucose total coefficient of variation (CV)(At sensor removal (day 14))
  • Time with Glucose < 70mg/dL(At sensor removal (day 14))

研究者

发起方
Centre Hospitalier Saint Joseph Saint Luc de Lyon
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验